Showing results (51-60 of 208) with videos related to

Sort By:
Pageof 21
Journal of Cell Communication and Signaling|January 15, 2011
CCN6 (WISP3): a new anti-cancer therapy?Andrew Leask
Journal of Cell Communication and Signaling|June 10, 2010
It's a knockout: CCN3 suppresses neointimal thickeningAndrew Leask
Frontiers in Bioscience (Elite Edition)|June 2, 2009
Signaling in fibrosis: targeting the TGF beta, endothelin-1 and CCN2 axis in sclerodermaAndrew Leask
Journal of Cell Communication and Signaling|November 14, 2016
CCN3: stopping that achy, breaky aortaAndrew Leask
Arthritis Research & Therapy|June 16, 2006
Scar wars: is TGFbeta the phantom menace in scleroderma?Andrew Leask
Cardiovascular Research|August 22, 2006
TGFbeta, cardiac fibroblasts, and the fibrotic responseAndrew Leask
Expert Opinion on Therapeutic Targets|July 16, 2013
CCN2: a novel, specific and valid target for anti-fibrotic drug interventionAndrew Leask
Expert Opinion on Emerging Drugs|April 27, 2012
Emerging targets for the treatment of sclerodermaAndrew Leask
Pageof 21